Fussel-18 inhibitors represent a class of chemical compounds characterized by their ability to selectively bind to and modulate the activity of the Fussel-18 protein, a molecule that plays a pivotal role in certain biochemical pathways within cells. The name "Fussel-18" itself comes from a nomenclature that typically relates to the sequence or discovery of the protein within a particular scientific investigation or its characteristic structure or function. These inhibitors are often highly specialized molecules, designed through an intricate process of medicinal chemistry, to achieve a high degree of specificity towards the Fussel-18 protein. This selectivity is crucial, as it ensures that the interaction with the target protein does not inadvertently affect other proteins with similar structures or functions, which could lead to undesired effects.
The chemical structure of Fussel-18 inhibitors is usually complex, featuring a core scaffold that interacts with the active site or a specific binding region on the Fussel-18 protein. Surrounding this core, there may be a variety of chemical groups-such as rings, chains, or heteroatoms-that enhance the inhibitor's affinity for the protein or its overall stability within biological systems. The development of these inhibitors often requires a deep understanding of the structure and dynamics of the Fussel-18 protein, obtained through techniques like X-ray crystallography or NMR spectroscopy. These structural insights allow chemists to design and synthesize Fussel-18 inhibitors that fit into the protein's architecture much like a key fits into a lock. The interaction between the inhibitor and the protein is typically governed by a combination of hydrogen bonds, hydrophobic interactions, and van der Waals forces, which together contribute to the potency and selectivity of the inhibitor.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits ALK5, ALK4, and ALK7, which are TGF-β type I receptors, and can prevent SMAD2/3 activation, potentially inhibiting Fussel-18 activity downstream. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Selectively inhibits TGF-β receptors I and II, possibly reducing SMAD2/3 phosphorylation affecting Fussel-18 activity. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $89.00 $275.00 | 9 | |
Inhibits TGF-β receptor I, which may decrease SMAD2/3-mediated transcription that could involve Fussel-18. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
Inhibits ALK5, and can thereby block TGF-β-induced SMAD2/3 phosphorylation, potentially affecting Fussel-18's function. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
Inhibits ALK5, ALK4, and ALK7, and can block SMAD2/3 phosphorylation, which may reduce Fussel-18 activity. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $88.00 | 3 | |
TGF-βRI kinase inhibitor that could inhibit SMAD2/3 activation and thus indirectly reduce Fussel-18 activity. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Inhibits TGF-β type I receptor ALK5, potentially diminishing SMAD2/3 phosphorylation and affecting Fussel-18. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
Has anti-fibrotic properties that include modulation of TGF-β activity, possibly affecting Fussel-18 indirectly. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Inhibits the release of TGF-β from cells and could indirectly inhibit Fussel-18's function in the pathway. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Inhibits Smad3 phosphorylation, which can lead to an inhibition of Fussel-18's activity if it is downstream of Smad3. | ||||||